Amylyx Pharmaceuticals Overview
Amylyx Pharmaceuticals Target Price
Analysts' 12-month price predictions for AMLX.
Get informed when a big investor buys or sells
+ FollowShare Price
$13.2
Average Target Price
$22.67
71.7% upside
71.7% upside3 analysts in the last 4 months
High: $28 | Low: $19
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-28 | Mizuho SecuritiesGraig Suvannavejh | $21 | 59.1% upside |  |
| 2026-02-19 | Mizuho Securities | $19 | 43.9% upside | |
| 2026-02-10 | H.C. WainwrightAndrew Fein | $28 | 112.1% upside | |
| 2025-10-29 | Mizuho Securities | $16 | 21.2% upside | |
| 2025-10-16 | Robert W. BairdJoel Beatty | $19 | 43.9% upside | |
| 2025-09-15 | GuggenheimSeamus Fernandez | $25 | 89.4% upside | |
| 2025-06-24 | GuggenheimSeamus Fernandez | $17 | 28.8% upside | |
| 2025-05-06 | Leerink PartnersMarc Goodman | $10 |  24.2% downside | |
| 2024-11-18 | Robert W. BairdJoel Beatty | $11 | 16.7% downside | |
| 2024-10-23 | Bank of America SecuritiesGeoff Meacham | $10 | 24.2% downside | |
| 2024-10-18 | H.C. WainwrightAndrew Fein | $8 | 39.4% downside | |
| 2024-10-18 | Leerink PartnersMarc Goodman | $4 | 69.7% downside | |
| 2024-05-14 | Mizuho SecuritiesGraig Suvannavejh | $3 | 77.3% downside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $3 | 77.3% downside | |
| 2024-04-04 | Deutsche BankNeena Bitritto-Garg | $4 | 69.7% downside | |
| 2024-03-17 | Mizuho SecuritiesGraig Suvannavejh | $4 | 69.7% downside | |